• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues-authors' reply.

作者信息

Wagner Josef, Littlejohn Margaret, Revill Peter A

机构信息

Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.

出版信息

Aliment Pharmacol Ther. 2023 Mar;57(5):583-584. doi: 10.1111/apt.17364.

DOI:10.1111/apt.17364
PMID:36786457
Abstract
摘要

相似文献

1
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues-authors' reply.社论：基线乙型肝炎病毒单倍型数量可能有助于预测接受核苷酸类似物治疗的慢性乙型肝炎患者的功能性治愈——作者回复
Aliment Pharmacol Ther. 2023 Mar;57(5):583-584. doi: 10.1111/apt.17364.
2
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues.社论：基线乙型肝炎病毒单倍型数量可能有助于预测接受核苷酸类似物治疗的慢性乙型肝炎患者的功能性治愈情况。
Aliment Pharmacol Ther. 2023 Mar;57(5):581-582. doi: 10.1111/apt.17328.
3
Letter: improved alanine aminotransferase level in non-cirrhotic and low-viral load chronic hepatitis B patients treated with nucleotide/nucleoside analogues -authors' reply.
Aliment Pharmacol Ther. 2023 Mar;57(5):589-590. doi: 10.1111/apt.17367.
4
Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues-authors' reply.社论：接受核苷（酸）类似物治疗的HBeAg阳性慢性乙型肝炎患者血清HBV RNA呈双相下降——作者回复
Aliment Pharmacol Ther. 2020 Sep;52(5):883-884. doi: 10.1111/apt.15993.
5
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B.基线时乙型肝炎病毒单倍型数量是基因型 A 和 D HBeAg 阳性慢性乙型肝炎患者抗病毒治疗中功能性治愈的预测标志物。
Aliment Pharmacol Ther. 2023 Mar;57(5):509-523. doi: 10.1111/apt.17299. Epub 2022 Nov 25.
6
Editorial: tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment-towards a better understanding of interferon responsiveness in chronic hepatitis B. Authors' reply.
Aliment Pharmacol Ther. 2022 Sep;56(6):1096-1097. doi: 10.1111/apt.17181.
7
[The relationship between serum HBV pgRNA and antigen status in patients with chronic hepatitis B after long-term nucleotide analogues treatment].[长期核苷类似物治疗后慢性乙型肝炎患者血清HBV pgRNA与抗原状态的关系]
Zhonghua Gan Zang Bing Za Zhi. 2021 Aug 20;29(8):766-770. doi: 10.3760/cma.j.cn501113-20200303-00083.
8
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.聚乙二醇干扰素 α-2a 联合核苷（酸）类似物治疗与单独核苷（酸）类似物治疗对 HBeAg 阴性慢性乙型肝炎患者持续不可检测的血浆乙型肝炎病毒 DNA 的影响：一项随机、对照、开放标签试验。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):177-188. doi: 10.1016/S2468-1253(16)30189-3. Epub 2017 Jan 20.
9
[Seroreversion and Acute Decompensation in Chronic Hepatitis B after Discontinuation of Oral Nucleotide Analog in the Patients Achieving HBsAg Loss].[实现HBsAg清除的慢性乙型肝炎患者停用口服核苷类似物后的血清学逆转和急性失代偿]
Korean J Gastroenterol. 2020 Nov 25;76(5):256-260. doi: 10.4166/kjg.2020.111.
10
Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues.
Aliment Pharmacol Ther. 2023 Mar;57(5):587-588. doi: 10.1111/apt.17329.